Gene therapy as a novel pharmaceutical intervention for stroke

Area of Science:

• Neuroscience
• Vascular Biology
• Gene Therapy

Background:

• Cerebrovascular disease, including stroke, is a major cause of mortality and disability globally.
• Current treatments for stroke have limitations, necessitating novel therapeutic strategies.

Purpose of the Study:

• To review novel gene transfer techniques for treating stroke.
• To explore the potential of gene therapy in addressing key pathological mechanisms of stroke.

Main Methods:

• Review of experimental studies on gene therapy for cerebrovascular disease.
• Analysis of gene transfer applications targeting neuronal protection, infarct size reduction, and functional recovery.
• Exploration of gene therapy for vasospasm prevention and neurogenesis promotion.

Main Results:

• Gene therapy has demonstrated efficacy in experimental models for neuroprotection, infarct reduction, and functional improvement.
• Gene transfer can target ischemia-induced apoptosis, inflammation, and neurovascular unit derangement.
• Potential for gene therapy in promoting neurogenesis and functional recovery, possibly combined with stem cell therapy.

Conclusions:

• Gene transfer techniques represent a promising avenue for novel stroke treatments.
• Targeting specific pathological pathways and promoting recovery mechanisms are key applications of gene therapy in stroke.
• Future research may focus on combining gene therapy with other regenerative approaches like stem cell therapy.